In the latest instalment of our clinical trials round-ups, we look at life sciences research and development announced during the week of 10th to 14th June, from early-stage onwards.
There’s a new biotech on the scene after MoonLake Immunotherapeutics launched on a mission to develop sonelokimab, a potential inflammatory diseases drug in-licensed from Germany’s Merck KG